US President Joe Biden's administration on Friday announced a new list of 15 drugs for which it will negotiate lower prices with pharmaceutical companies.

The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices ...

The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be ...

Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in ...

Medicare will negotiate drug prices for popular medications like Ozempic and Wegovy, aiming to save billions for taxpayers ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Increasing Prevalence of Asthma and COPD: The rising incidence of asthma and chronic obstructive pulmonary disease (COPD) ...